APTOF - Aptose Biosciences Inc.
1.6117
-0.024 -1.508%
Share volume: 9,327
Last Updated: 03-27-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$1.64
-0.02
-0.01%
View ratios
| Fiscal Date | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-08-2025 | 08-13-2025 | 11-13-2025 | |
| Cash flow financing | 829.000 K | 2.500 M | 7.750 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | |
| Cash flow | -1.966 M | 0.000 | 0.000 | |
| Net income | -5.543 M | -7.043 M | -5.123 M | |
| Depreciation | 3.000 K | 4.000 K | 11.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | 0.000 | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | |
| Cash Change | -1.964 M | -3.445 M | 339.000 K |